Quantitative trait locus linkage analysis in a large amish pedigree identifies novel candidate loci for erythrocyte traits

Molecular Genetics and Genomic Medicine

Volumn 1, Issue 3, 2013, Pages 131-141

  Hinckley, Jesse D ^a   Abbott, Diana ^b   Burns, Trudy L ^c   Heiman, Meadow ^d   Shapiro, Amy D ^d   Wang, Kai ^c   Di Paola, Jorge ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d INDIANA HEMOPHILIA AND THROMBOSIS CENTER   (United States)

Author keywords

Amish; Erythrocytes; Linkage; QTL

Indexed keywords

EID: 84990252549     PISSN: None     EISSN: 23249269     Source Type: Journal    
DOI: 10.1002/mgg3.16     Document Type: Article

References (47)

1. Ajioka, R. S., L. B. Jorde, J. R. Gruen, P. Yu, D. Dimitrova, J. Barrow, et al. 1997. Haplotype analysis of hemochromatosis:evaluation of different linkage-disequilibrium approachesand evolution of disease chromosoms. Am. J. Hum. Genet.60:1439–1447.
2. Allen, K. J., L. C. Gurrin, C. C. Constantine, N. J. Osborne, M. B. Delatycki, A. J. Nicoll, et al. 2008. Iron-overloadrelateddisease in HFE hereditary hemochromatosis. N. Engl. J. Med. 358:221–230.
3. Almasy, L., and J. Blangero. 1998. Multipoint quantitative-traitlinkage analysis in general pedigrees. Am. J. Hum. Genet.62:1198–1211.
4. Andersen, R. V., A. Tybjaerg-Hansen, M. Appleyard, H. Birgens, and B. G. Nordestgaard. 2004.Hemochromatosis mutations in the general population: ironoverload progression rate. Blood 103:2914–2919.
5. Benyamin, B., A. F. McRae, G. Zhu, S. Gordon, A. K. Henders, A. Palotie, et al. 2009. Variants in TF and HFE explain approximately 40% of genetic variation in serumtransferrinlevels. Am. J. Hum. Genet. 84:60–65.
6. Blangero, J., J. T. Williams, and L. Almasy. 2003. Novelfamily-based approaches to genetic risk in thrombosis. J. Thromb. Haemost. 1:1391–1397.
7. Chalmers, D. M., A. J. Levi, I. Chanarin, W. R. North, and T. W. Meade. 1979. Mean cell volume in a working population: the effects of age, smoking, alcohol and oralcontraception. Br. J. Haematol. 43:631–636.
8. Correas, I., D. W. Speicher, and V. T. Marchesi. 1986. Structure of the spectrin-actin binding site of erythrocyte protein 4.1. J. Biol. Chem. 261:13362–13366.
9. Costongs, G. M., P. C. Janson, B. M. Bas, J. Hermans, P. J. Brombacher, and J. W. van Wersch. 1985. Short-term and long-term intra-individual variations and criticaldifferences of haematological laboratory parameters. J. Clin. Chem. Clin. Biochem. 23:69–76.
10. Dal Colletto, G. M., D. W. Fulker, O. C. Barretto, and M. Kolya. 1993. Genetic and environmental effects on bloodcells. Acta. Genet. Med. Gemellol. (Roma) 42:245–252.
11. Desch, K. C., A. B. Ozel, D. Siemieniak, Y. Kalish, J. A. Shavit, C. D. Thornburg, et al. 2013. Linkage analysis identifies alocus for plasma von Willebrand factor undetected bygenome-wide association. Proc. Natl. Acad. Sci. USA 110:588–593.
12. Drakesmith, H., E. Sweetland, L. Schimanski, J. Edwards, D. Cowley, M. Ashraf, et al. 2002. The hemochromatosisprotein HFE inhibits iron export from macrophages. Proc. Natl. Acad. Sci. USA 99:15602–15607.
13. Evans, D. M., I. H. Frazer, and N. G. Martin. 1999. Geneticand environmental causes of variation in basal levels ofblood cells. Twin Res. 2:250–257.
14. Fairbanks, G., T. L. Steck, and D. F. Wallach. 1971.Electrophoretic analysis of the major polypeptides of thehuman erythrocyte membrane. Biochemistry 10:2606–2617.
15. Feder, J. N., A. Gnirke, W. Thomas, Z. Tsuchihashi, D. A. Ruddy, A. Basava, et al. 1996. A novel MHC class I-likegene is mutated in patients with hereditaryhaemochromatosis. Nat. Genet. 13:399–408.
16. Feder, J. N., D. M. Penny, A. Irrinki, V. K. Lee, J. A. Lebron, N. Watson, et al. 1998. The hemochromatosis gene productcomplexes with the transferrin receptor and lowers itsaffinity for ligand binding. Proc. Natl. Acad. Sci. USA 95:1472–1477.
17. Felker, G. M., L. A. Allen, S. J. Pocock, L. K. Shaw, J. J. McMurray, M. A. Pfeffer, et al. 2007. Red cell distributionwidth as a novel prognostic marker in heart failure: datafrom the CHARM Program and the Duke Databank. J. Am.Coll. Cardiol. 50:40–47.
18. Gagnon, D. R., T. J. Zhang, F. N. Brand, and W. B. Kannel.1994. Hematocrit and the risk of cardiovascular disease–theFramingham study: a 34-year follow-up. Am. Heart J.127:674–682.
19. Ganesh, S. K., N. A. Zakai, F. J. van Rooij, N. Soranzo, A. V. Smith, M. A. Nalls, et al. 2009. Multiple loci influenceerythrocyte phenotypes in the CHARGE Consortium. Nat. Genet. 41:1191–1198.
20. Garner, C., T. Tatu, J. E. Reittie, T. Littlewood, J. Darley, S. Cervino, et al. 2000. Genetic influences on F cells andother hematologic variables: a twin heritability study. Blood 95:342–346.
21. Haltmayer, M., T. Mueller, C. Luft, W. Poelz, and D. Haidinger. 2002. Erythrocyte mean corpuscularvolume associated with severity of peripheral arterialdisease: an angiographic evaluation. Ann. Vasc. Surg. 16:474–479.
22. Heath, S. C. 1997. Markov chain Monte Carlo segregation andlinkage analysis for oligogenic models. Am. J. Hum. Genet.61:748–760.
23. Heutink, P., and B. A. Oostra. 2002. Gene finding ingenetically isolated populations. Hum. Mol. Genet. 11:2507–2515.
24. Iliadou, A., D. M. Evans, G. Zhu, D. L. Duffy, I. H. Frazer, G. W. Montgomery, et al. 2007. Genomewide scans of redcell indices suggest linkage on chromosome 6q23. J. Med. Genet. 44:24–30.
25. Kabeche, L., and D. A. Compton. 2012. Checkpointindependentstabilization of kinetochore-microtubule attachments by Mad2 in human cells. Curr. Biol. 22:638–644.
26. Kamatani, Y., K. Matsuda, Y. Okada, M. Kubo, N. Hosono, Y. Daigo, et al. 2010. Genome-wide association study ofhematological and biochemical traits in a Japanesepopulation. Nat. Genet. 42:210–215.
27. Lin, J. P., C. J. O’Donnell, D. Levy, and L. A. Cupples. 2005. Evidence for a gene influencing haematocrit on chromosome 6q23-24: genomewide scan in the FraminghamHeart Study. J. Med. Genet. 42:75–79.
28. Lo, K. S., J. G. Wilson, L. A. Lange, A. R. Folsom, G. Galarneau, S. K. Ganesh, et al. 2011. Genetic association analysis highlights new loci that modulate hematologicaltrait variation in Caucasians and African Americans. Hum.Genet. 129:307–317.
29. Madjid, M., I. Awan, J. T. Willerson, and S. W. Casscells. 2004. Leukocyte count and coronary heart disease: implications for risk assessment. J. Am. Coll. Cardiol.44:1945–1956.
30. Milet, J., V. Dehais, C. Bourgain, A. M. Jouanolle, A. Mosser, M. Perrin, et al. 2007. Common variants in the BMP2, BMP4, and HJV genes of the hepcidin regulation pathwaymodulate HFE hemochromatosis penetrance. Am. J. Hum.Genet. 81:799–807.
31. Nikolsky, E., C. L. Grines, D. A. Cox, E. Garcia, J. E. Tcheng, M. Sadeghi, et al. 2007. Impact of baseline platelet count inpatients undergoing primary percutaneous coronaryintervention in acute myocardial infarction (from the CADILLAC trial). Am. J. Cardiol. 99:1055–1061.
32. O’Connell, J. R., and D. E. Weeks. 1998. PedCheck: a programfor identification of genotype incompatibilities in linkageanalysis. Am. J. Hum. Genet. 63:259–266.
33. Ozsu, S., Y. Abul, S. Gunaydin, A. Orem, and T. Ozlu. 2012. Prognostic Value of Red Cell Distribution Width in PatientsWith Pulmonary Embolism. Clin ApplThrombHemost.
34. Puddu, P. E., M. Lanti, A. Menotti, M. Mancini, A. Zanchetti, M. Cirillo, et al. 2002. Red blood cell count in short-termprediction of cardiovascular disease incidence in the Gubbiopopulation study. Acta Cardiol. 57:177–185.
35. Ranade, K., M. S. Chang, C. T. Ting, D. Pei, C. F. Hsiao, M. Olivier, et al. 2001. High-throughput genotyping with singlenucleotide polymorphisms. Genome Res. 11:1262–1268.
36. Schwartz, J., and S. T. Weiss. 1991. Host and environmentalfactors influencing the peripheral blood leukocyte count. Am. J. Epidemiol. 134:1402–1409.
37. Schwarz, K., A. Iolascon, F. Verissimo, N. S. Trede, W. Horsley, W. Chen, et al. 2009. Mutations affecting the secretory COPII coat component SEC23B cause congenitaldyserythropoieticanemia type II. Nat. Genet. 41:936–940.
38. Tomari, K., T. Kumagai, T. Shimizu, and K. Takeda. 2005.Bone morphogenetic protein-2 induceshypophosphorylation of Rb protein and repression of E2Fin androgen-treated LNCaP human prostate cancer cells. Int. J. Mol. Med. 15:253–258.
39. Tonelli, M., F. Sacks, M. Arnold, L. Moye, B. Davis, and M. Pfeffer. 2008. Relation Between Red Blood Cell Distribution Width and Cardiovascular Event Rate in People With Coronary Disease. Circulation 117:163–168.
40. Walters, M. C., and H. T. Abelson. 1996. Interpretation ofthe complete blood count. Pediatr. Clin. North Am. 43:599–622.
41. Wang, X., Y. Song, J. Ren, and X. Qu. 2009. Knocking-downcyclin A(2) by siRNA suppresses apoptosis and switchesdifferentiation pathways in K562 cells upon administrationwith doxorubicin. PLoS One 4:e6665.
42. Whitehead, T. P., D. Robinson, S. L. Allaway, and A. C. Hale.1995. The effects of cigarette smoking and alcohol consumption on blood haemoglobin, erythrocytes andleucocytes: a dose related study on male subjects. Clin. Lab. Haematol. 17:131–138.
43. Whitfield, J. B., and N. G. Martin. 1985. Genetic andenvironmental influences on the size and number of cells in the blood. Genet. Epidemiol. 2:133–144.
44. Williams, J. H., L. N. Daly, E. Ingley, J. G. Beaumont, P. A. Tilbrook, J. P. Lalonde, et al. 1999. HLS7, a hemopoieticlineage switch gene homologous to the leukemia-inducinggene MLF1. EMBO J. 18:5559–5566.
45. Yang, Q., S. Kathiresan, J. P. Lin, G. H. Tofler, and C. J. O’Donnell. 2007. Genome-wide association and linkage analyses of hemostatic factors and hematological phenotypesin the Framingham Heart Study. BMC Med. Genet. 8Suppl.1:S12.
46. Ye, Z., C. Smith, and I. J. Kullo. 2011. Usefulness of redcell distribution width to predict mortality in patients with peripheral artery disease. Am. J. Cardiol. 107:1241–1245.
47. Yokoyama, Y., and T. Akiyama. 1995. Intrapair differences ofthe blood cell components and lymphocyte subsets inmonozygotic and dizygotic twins. Acta. Genet. Med. Gemellol. (Roma) 44:203–214.